Consolidated Statements of Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 29, 2024		Dec. 31, 2023		Dec. 25, 2022		Dec. 26, 2021
Dividends declared per common share (in dollars per share)	$ 1.84		$ 1.76		$ 1.54
Net income (loss) allocated to the redeemable noncontrolling interest from joint venture arrangements	$ 274		$ 198		$ 574
Stockholders' deficit	414,216		443,616		270,664		$ 172,458
Transaction costs on share repurchases			2,804
Accumulated other comprehensive loss
Stockholders' deficit	8,456	[1]	7,803	[1],[2]	10,135	[2],[3]	$ 9,971	[3]
Net unrealized foreign currency translation loss
Stockholders' deficit	8,332		7,490		8,696
Net unrealized loss on interest rate swap agreements
Stockholders' deficit	124		314		1,439
Corporate joint venture
Net income (loss) allocated to the redeemable noncontrolling interest from joint venture arrangements	$ 274		$ 198		$ 574

[1] At December 29, 2024, the accumulated other comprehensive loss of $8,456 was comprised of net unrealized foreign currency translation loss of $8,332 and a net unrealized loss on the interest rate swap agreements of $124.

[2] At December 31, 2023, the accumulated other comprehensive loss of $7,803 was comprised of net unrealized foreign currency translation loss of $7,490 and a net unrealized loss on the interest rate swap agreements of $314.

[3] At December 25, 2022, the accumulated other comprehensive loss of $10,135 was comprised of net unrealized foreign currency translation loss of $8,696 and a net unrealized loss on the interest rate swap agreements of $1,439.